David Kwok is the founder and President of BRI Biopharmaceutical Research Inc., a GLP/cGMP analytical, bioanalytical and DM/PK contract research company established in 1991 that integrates pre-clinical and clinical services to accelerate the pace of drug candidate and pre-clinical product development from lead-optimization to phase-I/II studies. BRI provides an integrated pre-clinical development program including CMC analytical chemistry, bioanalytical LC/MS/MS assays, in vitro/in vivo ADME and DM/PK studies, formulation development and clinical product manufacturing in collaboration with a network of contract research providers in Canada and the US. Dr. Kwok graduated from the University of British Columbia, Canada, with a B.Sc. Degree in pharmacy in 1984, M.Sc. and Ph.D. in medicinal chemistry in 1991. He served in a variety of scientific and management posts at Health Canada from 1991 to 1998, involving botanical natural health products quality control, antimicrobial drug resistance and veterinary drug safety programs. He has been an invited speaker at numerous professional conferences and workshops including contributions to numerous scientific publications on the topics of bioanalytical assays, drug metabolism and pharmacokinetics in peer-reviewed journals, conference posters and international patents.